Regulated expression of a foreign gene targeted to the ischaemic myocardium

Cardiovascular Research

Volumn 35, Issue 3, 1997, Pages 567-574

  Prentice, Howard ^d   Bishopric, Nanette H ^a,b   Hicks, Martin N ^c   Discher, Daryl J ^a,b   Wu, Xiaosu ^a   Wylie, Andrew A ^d   Webster, Keith A ^a,b  

^a SRI INTERNATIONAL   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d RINICOM LTD   (United Kingdom)

Author keywords

Cardioprotection; Gene therapy; Hypoxia; Redox

Indexed keywords

VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE TARGETING; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HUMAN; HUMAN CELL; HYPOXIA; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RABBIT; RAT;

ANIMALS; ANOXIA; CELLS, CULTURED; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENES, REGULATOR; MALE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOSIN HEAVY CHAINS; OXIDATION-REDUCTION; RABBITS; RATS;

EID: 0030815312     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00158-2     Document Type: Article

References (64)

1. Muhlhauser J., Jones M., Yamada I.et al. Safety and efficacy of in vivo gene transfer into the porcine heart with replication-deficient, recombinant adenovirus vectors. Gene Ther. 3:1996;145-153.
2. Kirshenbaum L.A., MacLennan W.R., Mazur W., French B.A., Schneider M.D. Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus. J Clin Invest. 92:1993;381-387.
3. Subramaniam A., Gulick J., Neumann J., Knotts S., Robbins J. Transgenic analysis of the thyroid-responsive elements in the α-cardiac myosin heavy chain gene promoter. J Biol Chem. 268:1993;4331-4336.
4. Magovern C.J., Mack C.A., Zhang J.et al. Direct in vivo gene transfer to canine myocardium using a replication-deficient adenovirus vector. Ann Thorac Surg. 62:1996;425-433. Discussion.
5. Barr E., Carroll J., Kalynych A.M.et al. Efficient catheter-mediated gene transfer into the heart using replication-defective adenovirus. Gene Ther. 1:1994;51-58.
6. Li J.J., Ueno H., Pan Y.et al. Percutaneous transluminal gene transfer into canine myocardium in vivo by replication-defective adenovirus. Cardiovasc Res. 30:1995;97-105.
7. French B.A., Mazur W., Geske R.S., Bolli R. Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation. 90:1994;2414-2424.
8. Kaplitt M.G., Xiao X., Samulski R.J.et al. Long-term gene transfer in porcine myocardium after coronary infusion of an adeno-associated virus vector. Ann Thorac Surg. 62:1996;1669-1676.
9. Coffin R.S., Howard M.K., Cummings D.V.E.et al. Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors. Gene Ther. 3:1996;560-566.
10. Miller N., Vile R. Targeted vectors for gene therapy. FASEB J. 9:1995;190-199.
11. Nabel E.G. Gene therapy for cardiovascular disease. Circulation. 91:1995;541-548.
12. Sawa Y., Suzuki K., Bai H.Z.et al. Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome. Circulation. 92:1995;II479-II482.
13. Ellison K.E., Bishopric N.H., Webster K.A.et al. Fusigenic liposome-mediated DNA transfer into cardiac myocytes. J Mol Cell Cardiol. 28:1996;1385-1399.
14. Allen T.M. Long-circulating (sterically stabilized) liposomes for targeted drug delivery. Trends Physiol Sci. 15:1994;215-220.
15. Metzger J.M., Parmacek M.S., Barr E.et al. Skeletal troponin C reduces contractile sensitivity to acidosis in cardiac myocytes from transgenic mice. Proc Natl Acad Sci USA. 90:1993;9036-9040.
16. Milano C.A., Allen L.F., Rockman H.A.et al. Enhanced myocardial function in transgenic mice overexpressing the β-2-adrenergic receptor. Science. 264:1994;582-586.
17. Giordano F.J., Ping P., McKirnan M.D.et al. Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischaemic region of the heart. Nat Med. 2:1996;534-539.
18. Ping P., Yang Q., Hammond H.K. Altered beta-adrenergic receptor signaling in heart failure, in vivo gene transfer via adeno and adeno-associated virus. Microcirculation. 3:1996;225-228.
19. Acsadi G., Lochmuller H., Jani A.et al. Dystrophin expression in muscles of mdx mice after adenovirus-mediated in vivo gene transfer. Hum Gene Ther. 7:1996;129-140.
20. Marian A.J., Yu Q.T., Mann D.L., Graham F.L., Roberts R. Expression of a mutation causing hypertrophic cardiomyopathy disrupts sarcomere assembly in adult feline cardiac myocytes. Circ Res. 77:1995;98-106.
21. Quinones M.J., Leor J., Kloner R.A.et al. Avoidance of immune response prolongs expression of genes delivered to the adult rat myocardium by replication-defective adenovirus. Circulation. 94:1996;1394-1401.
22. Prentice H., Kloner R., Prigozy T.et al. Tissue restricted gene expression assayed by direct DNA injection into cardiac and skeletal muscle. J Mol Cell Cardiol. 26:1994;1393-1401.
23. Molkentin J.D., Kalvakolanu D.V., Markham B.E. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the alpha-myosin heavy-chain gene. Mol Cell Biol. 14:1994;5056-5065.
24. Franz W.-M., Breves D., Klingel K., Brem G., Hofschneider P.H., Kandolf R. Heart-specific targeting of firefly luciferase by the myosin light chain-2 promoter and developmental regulation in transgenic mice. Circ Res. 73:1993;629-638.
25. Kitsis R.N., Buttrick P.M., McNally E.M., Kaplan M.L., Leinwand L.A. Hormonal modulation of a gene injected into the rat heart in vivo. Proc Natl Acad Sci USA. 88:1991;4138-4142.
26. Fishman G.I., Kaplan M.L., Buttrick P.M. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest. 93:1994;1864-1868.
27. Koh G.Y., Kim S.J., Klug M.G.et al. Targeted expression of transforming growth factor-beta 1 in intracardiac grafts promotes vascular endothelial cell DNA synthesis. J Clin Invest. 95:1995;114-121.
28. Entman M.L., Michael L., Rossen R.D.et al. Inflammation in the course of early myocardial ischaemia. FASEB J. 5:1991;2529-2537.
29. Williams F.M., Kus M., Tanda K., Williams T.J. Effect of duration of ischaemia on reduction of myocardial infarct size by inhibition of neutrophil accumulation using an anti-CD18 monoclonal antibody. Br J Pharmacol. 111:1994;1123-1128.
30. Maclean D., Fishbein M.C., Braunwald E., Maroko P.R. Long term preservation of ischaemic myocardium after experimental coronary artery occlusion. J Clin Invest. 61:1978;541-551.
31. Satriano J.A., Shuldiner M., Hora K.et al. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-α and immunoglobin G. J Clin Invest. 92:1993;1564-1571.
32. Ivey C.L., Williams F.M., Collins P.D., Jose P.J., Williams T.J. Neutrophil chemoattractants generated in two phases during reperfusion of ischaemic myocardium in the rabbit. J Clin Invest. 95:1995;2720-2728.
33. Galinanes M., Lawson C.S., Ferrari R.et al. Early and late effects of leukopenic reperfusion on the recovery of cardiac contractile function. Circulation. 88:1993;673-683.
34. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest. 94:1994;1612-1628.
35. Ma X., Weyrich A.S., Lefer D.J.et al. Monoclonal antibody to L-selectin attenuates neutrophil accumulation and protects ischaemic reperfused cat myocardium. Circulation. 88:1993;649-658.
36. Marber M.S., Latchman D.S., Walker J.M., Yellon D.M. Cardiac stress protein elevation 24 hours after brief ischaemia or heat stress is associated with resistance to myocardial infarction. Circulation. 88:1993;1264-1272.
37. Mestril R., Chi S.H., Sayen M.R., O'Reilly K., Dillmann W.H. Expression of inducible stress protein 70 in rat heart myogenic cells confers protection against simulated ischaemia-induced injury. J Clin Invest. 93:1994;759-767.
38. Yang B.C., Virmani R., Nichols W.W., Mehta J.L. Platelets protect against myocardial dysfunction and injury induced by ischaemia and reperfusion in isolated rat hearts. Circ Res. 72:1993;1181-1190.
39. Taylor S.H. Congestive heart failure: towards a comprehensive treatment. Eur Heart J. 17(Suppl B):1996;43-56.
40. Steare S.E., Yellon D.M. The potential for endogenous myocardial antioxidants to protect the myocardium against ischaemia-reperfusion injury. J Mol Cell Cardiol. 27:1995;65-74.
41. Stenman C.L., Shutter J.R., Hockenbery D., Kanagawa O., Korsemeyer S.J. Bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 67:1991;879-888.
42. Kiefer M.C., Brauer M.J., Powers V.C.et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature. 374:1995;736-739.
43. Semenza G.L., Nejfelt M.K., Chi S.M., Antonarakis S.E. Hypoxia-inducible nuclear factors bind to an enhancer element located 3′ to the human erythropoietin gene. Proc Natl Acad Sci USA. 88:1991;5680-5684.
44. Gustafson T.A., Markham B.E., Bahl J.J., Morkin E. Thyroid hormone regulates expression of a transfected alpha-myosin heavy chain fusion gene in fetal heart cells. Proc Natl Acad Sci USA. 84:1987;3122-3126.
45. Molkentin J.D., Jobe S.M., Markham B.E. Alpha-myosin heavy chain gene regulation: delineation and characterization of the cardiac muscle-specific enhancer and muscle-specific promoter. J Mol Cell Cardiol. 28:1996;1211-1225.
46. Bishopric N.H., Simpson P.C., Ordahl C.P. Induction of the skeletal actin gene in α1-adrenoceptor mediated hypertrophy of rat cardiac myocytes. J Clin Invest. 80:1987;1194-1199.
47. Webster K.A., Bishopric N.H. Molecular regulation of cardiac myocyte adaptations to chronic hypoxia. J Mol Cell Cardiol. 24:1992;741-751.
48. Penney DG. Carbon dioxide induced cardiac hypertrophy. In: Zak R., editor. Growth of the heart in health and disease. New York: Raven Press, 1984:337-62.
49. Webster K.A., Muscat G.E.O., Kedes L. Adenovirus E1A products suppress myogenic differentiation and inhibit transcription from muscle-specific promoters. Nature. 332:1988;553-558.
50. Webster K.A., Kedes L. The c-fos cyclic AMP-responsive element conveys constitutive expression to a tissue-specific promoter. Mol Cell Biol. 10:1990;2402-2406.
51. Bodi I., Bishopric N.H., Discher D.J., Wu X., Webster K.A. Cell-specificity and signaling pathway of endothelin-1 gene regulation by hypoxia. Cardiovasc Res. 30:1995;975-984.
52. Wu X., Bishopric N.H., Discher D.J., Murphy B.J., Webster K.A. Physical and functional sensitivity of zinc finger transcription factors to redox change. Mol Cell Biol. 16:1996;1035-1046.
53. Prentice H., Kloner R.A., Li Y., Newman L., Kedes L. Ischaemic/reperfused myocardium can express recombinant protein following direct DNA or retroviral injection. J Mol Cell Cardiol. 28:1996;133-140.
54. Webster K.A., Discher D., Bishopric N.H. Induction and nuclear accumulation of fos and jun proto-oncogenes in hypoxia cardiac myocytes. J Biol Chem. 268:1993;16852-16859.
55. Webster K.A., Discher D.J., Bishopric N.H. Regulation of fos and jun immediate-early genes by redox or metabolic stress in cardiac myocytes. Circ Res. 75:1994;361-371.
56. Denver M.A., MacFarlane N.G., Miller D.J., Cobbe S.M. Enhance SR function in saponin-treated ventricular trabeculae from rabbits with heart failure. Am J Physiol. 271:1996;H850-H859.
57. Mahdavi V, Koren G, Michaud S, Pinset C, Izumo S. Identification of the sequences responsible for the tissue-specific and hormonal regulation of the cardiac myosin heavy chain genes. In: Kedes LH, Stockdale FE, editors. Cellular and molecular biology of muscle development. New York: Alan R. Liss, 1989:369-79.
58. Buttrick P.M., Kass A., Kitsis R.N., Kaplan M.L., Leinwand L.A. Behavior of genes directly injected into the rat heart in vivo. Circ Res. 70:1992;193-198.
59. Buttrick P.M., Kaplan M.L., Kitsis R.N., Leinwand L.A. Distinct behavior of cardiac myosin heavy chain gene constructs in vivo. Circ Res. 72:1993;1211-1217.
60. Bunn H.F., Poyton R.O. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev. 76:1996;839-885.
61. 2 tension. Proc Natl Acad Sci USA. 92:1995;5510-5514.
62. Jelkmann W. Erythropoietin: structure, control of production, and function. Physiol Rev. 72:1992;449-489.
63. Hockenbery D.M., Oltval Z.L., Yin X.-M., Milliman C.L., Korsmeyer S.J. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 75:1993;241-251.
64. Gibbons G.H., Dzau V.J. Molecular therapies for vascular diseases. Science. 272:1996;689-693.